Log in to save to my catalogue

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator i...

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bdceb0ff675d43a98e7c4e869966cc73

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

About this item

Full title

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2021-01, Vol.7 (1), p.e001396

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

ObjectivesTo evaluate an intervention to reduce the nocebo effect (NE) when switching from the originator infliximab (OI) to the infliximab biosimilar SB2 in chronic inflammatory rheumatic disease (CIRD).MethodsAn intervention was built with healthcare professionals (HPs) and a patient representative, based on a systematic review of interventions r...

Alternative Titles

Full title

Multidisciplinary team intervention to reduce the nocebo effect when switching from the originator infliximab to a biosimilar

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_bdceb0ff675d43a98e7c4e869966cc73

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_bdceb0ff675d43a98e7c4e869966cc73

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2020-001396

How to access this item